Company overview
The tracked entity, USA Angelalign Technology Corp., is the U.S. arm of Angelalign Technology Inc. (HKEX: 6699), a Cayman-incorporated holding company headquartered in Shanghai's Yangpu District. Angelalign was founded in 2003 and listed on the Hong Kong Stock Exchange in June 2021. It is publicly traded with a broad international shareholder base and is described as a subsidiary of CareCapital Orthotech Limited. Reported headcount is roughly 4,300–4,500 employees, with TTM revenue of about HK$3.45 billion (approx. US$440 million) and a market capitalization around HK$14.5 billion, per financial data aggregators.
Products / services
Angelalign designs, manufactures, and sells clear orthodontic aligner systems — custom removable aligners that reposition teeth over a treatment course. Its main lines include Angel Aligner Pro and Angel Aligner Select, the KiD early-orthodontic system, retainers, and the masterControl S multilayer polymer material. It also markets the angelAttach precision attachment system, the A6/A7 mandibular advancement and premolar extraction solutions, intraoral scanners and brackets, and the iOrtho digital orthodontic planning platform. Beyond aligners, it operates dental clinics offering orthodontic and cosmetic dentistry services. This is an operating company, not a non-practicing entity.
Patent-litigation posture
Per the tracked data, the company appears only as a defendant (0 plaintiff, 1 defendant cases). It is an operating company defending patent-infringement claims, not an NPE. The single tracked suit sits in the plaintiff-friendly Eastern District of Texas, Marshall Division, before Judge J. Rodney Gilstrap.
Notable case and context
Align Technology, Inc. v. Angelalign Technology Inc. et al. (E.D. Tex., No. 2:25-cv-00804, filed 2025-08-18) names Angelalign and affiliated Wuxi and Shanghai EA entities. Align, the Invisalign maker and Angelalign's larger competitor, asserts aligner-material and attachment/bite-ramp patents. Related proceedings include an ITC action (the district case was moved to stay pending it) and parallel suits in Europe and China. A Düsseldorf Unified Patent Court division declined Align's preliminary injunction request in May 2026, and a Zhengzhou court reportedly rejected Align's claims at first instance in July 2026; those rulings were subject to appeal as of reporting. None of this reflects any determination on the U.S. case's merits.